Long-term air pollution exposure and markers of cardiometabolic health in the National Longitudinal Study of Adolescent to Adult Health (Add Health) Study

Mercedes A. Bravo, Fang Fang, Dana B. Hancock, Eric O. Johnson, Kathleen Mullan Harris
doi: https://doi.org/10.1101/2022.12.07.22283112

ABSTRACT

Background Air pollution exposure is associated with cardiovascular morbidity and mortality. Although exposure to air pollution early in life may represent a critical window for development of cardiovascular disease risk factors, few studies have examined associations of long-term air pollution exposure with markers of cardiovascular and cardiometabolic health in young adults.

Objectives By combining health data from the National Longitudinal Study of Adolescent to Adult Health (Add Health) with air pollution data from the Fused Air Quality Surface using Downscaling (FAQSD) archive, we: (1) calculated multi-year estimates of exposure to ozone (O3) and particulate matter with an aerodynamic diameter ≤2.5μm (PM2.5) for Add Health participants; and (2) estimated associations between air pollution exposures and multiple markers of cardiometabolic health.

Methods Add Health is a nationally representative longitudinal cohort study of over 20,000 adolescents aged 12–19 in the United States (US) in 1994–95 (Wave I). Participants have been followed through adolescence and into adulthood with five in-home interviews. Estimated daily concentrations of O3 and PM2.5 at census tracts were obtained from the FAQSD archive and used to generate tract-level annual averages of O3 and PM2.5 concentrations. We estimated associations between average O3 and PM2.5 exposures from 2002–07 and markers of cardiometabolic health measured at Wave IV (2008–09), including hypertension, hyperlipidemia, body mass index (BMI), diabetes, C-reactive protein, and metabolic syndrome.

Results The final sample size was 11,259 individual participants. The average age of participants at Wave IV was 28.4 years (range: 24–34 years). In models adjusting for age, race/ethnicity, and sex, long-term O3 exposure (2002–07) was associated with elevated odds of hypertension, with an odds ratio (OR) of 1.015 (95% confidence interval [CI]: 1.011, 1.029); obesity (1.022 [1.004, 1.040]); diabetes (1.032 [1.009,1.054]); and metabolic syndrome (1.028 [1.014, 1.041]); PM2.5 exposure (2002–07) was associated with elevated odds of hypertension (1.022 [1.001, 1.045]).

Conclusion Findings suggest that long-term ambient air pollution exposure, particularly O3 exposure, is associated with cardiometabolic health in early adulthood.

INTRODUCTION

An extensive literature has demonstrated that exposure to ambient air pollution has wide-ranging harmful effects on health.1 Exposures to ozone (O3) and particulate matter with an aerodynamic diameter ≤2.5μm (PM2.5) are linked with cardiovascular and respiratory-related mortality,2-4 morbidity, 5-8 and hospital admissions,9,10 even at concentrations below the National Ambient Air Quality Standards.11,12 A growing body of research has investigated the relationship between air pollution exposure, particularly traffic-related air pollution exposure, and risk factors for early markers of cardiovascular disease. Evidence increasingly suggests that exposure to air pollutants is associated with risk factors for early indicators of cardiovascular disease that may develop years or decades prior to clinical manifestations of more severe disease.13

Specifically, chronic exposure to air pollution early in the life course may directly affect development of major risk factors for cardiovascular disease, including obesity, hypertension, and metabolic disorders. Studies have documented associations between residential proximity to roads and arterial stiffness,14 an early-stage indicator of atherosclerosis, and the underlying cause of most cardiovascular disease. There is also evidence to suggest that long-term exposure to air pollution, including PM2.5 and O3, is associated with accelerated atherosclerosis,15 elevated blood pressure and increased mean arterial pressure,16, obesity,17,18 and diabetes.19,20 Much of the work on air pollution and cardiovascular disease risk has focused on middle-aged and older adults, e.g., ≥45 years, the demographic age group at highest risk for morbidity and mortality associated with cardiovascular disease.

However, exposure to air pollution during early developmental stages (childhood, adolescence, and early adulthood) may represent critical windows for development of risk factors for cardiovascular disease. For example, a 2021 study of children in Los Angeles, CA, observed that children with higher exposure to traffic-related air pollution had greater annual change in carotid artery intima-media thickness, a measure indicative of subclinical atherosclerosis.21 Jerrett et al. examined traffic pollution around children’s residences and observed that higher levels of traffic-related air pollution were associated with higher body mass index (BMI) in children 10-18 years, particularly in females.22 Li et al. studied adults aged 18 to 29 and found that high concentrations of some air pollutants were associated with impairments in high-density lipoprotein (HDL) functionality,23 and McGuinn et al. found that long-term PM2.5 exposure was associated with lipoprotein increases in adults.24 Studies of air pollution exposure and cardiometabolic outcomes in children, adolescents, or young adults are few, often have shorter follow up periods, and tend to be based on small or non-representative samples in localized geographic areas.23,25,26

The National Longitudinal Study of Adolescent to Adult Health (Add Health) is a nationally representative cohort of 20,745 individuals in the United States (US). Add Health participants were enrolled as adolescents aged 12-19 years in 1994–95 and have been followed through adolescence and into adulthood until, most recently, 2016–18.27 Add Health and its collection of individual-level measures of cardiometabolic health offer an important and unique opportunity to further our understanding of potential adverse health effects of air pollution exposures that occur in early adulthood. Markers of cardiometabolic health can provide insight into underlying biological processes in premorbid disease pathways and may indicate biological dysfunction before clinical manifestation of more severe disease.

In this study, we used publicly available daily estimates of ambient concentrations of two criteria air pollutants, PM2.5 and O3, to generate annual average exposure estimates, and merged these to Add Health participants based on census tract(s) of residence across the multiple waves of Add Health. We then: (1) evaluated whether multi-year averages of air pollutant exposure prior to Wave IV, which occurred in 2008–09, differed by individual-level characteristics (e.g., race/ethnicity, sex); and (2) estimated associations between air pollution exposure and six markers of cardiometabolic health measured at Wave IV: hypertension, hyperlipidemia, obesity, diabetes, C-reactive protein, and a summary measure of metabolic syndrome. This is the first study of long-term air pollution exposure in Add Health and, to the best of our knowledge, one of a limited number of studies examining air pollution exposures and cardiometabolic health in a cohort of young adults.26

METHODS

Add Health cohort

We used data from the National Longitudinal Study of Adolescent to Adult Health (Add Health), an ongoing, nationally representative cohort of adolescents in grades 7–12 during the 1994–95 school year. Add Health used a multistage, stratified, school-based, cluster sampling design to select a probability sample of more than 20,000 adolescents from school rosters for in-home interviews at Wave I (WI) in 1994–95 (ages 12–19). The cohort has been followed up with four subsequent interviews: WII in 1996 (ages 13–20); WIII in 2001–02 (ages 18–26); WIV in 2008–09 (ages 24–32); and WV in 2016–18 (ages 33–43).27,28 Response rates have ranged from 72% to 90% across waves, and non-response bias has been minimal.29,30 Details on the Add Health study objectives, design, and sampling strategy are provided elsewhere.27,28

For the exposure measures, the present paper uses Add Health participant data from Waves I, III, and IV with recently constructed and merged air pollution data, as described later. For the cardiometabolic health markers, we used the biological and clinical data collected at Wave IV (response rate=80.3%), including systolic and diastolic blood pressure; lipid panels; measured height and weight used to calculate BMI; indicators of diabetes (e.g., fasting or non-fasting glucose and/or glycated hemoglobin [HbA1c]); and concentrations of C-reactive protein as a measure of inflammation.31 We examined six key markers of cardiometabolic health at Wave IV: hypertension, hyperlipidemia, obesity, diabetes, and C-reactive protein concentration, and a summary measure of metabolic syndrome. Following clinical guidelines to identify the high-risk category, all cardiometabolic health markers were coded as binary variables (0/1) and defined as follows.

Hypertension was indicated if participants met at least one of the following criteria: having stage 1 or stage 2 hypertension according to the guidelines from the Seventh Report of the Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure (JNC7): systolic blood pressure of 140–159 mm Hg or diastolic blood pressure of 80–89 mm Hg for stage 1 hypertension; systolic blood pressure of ≥160 mm Hg or diastolic blood pressure of ≥100 mm Hg for stage 2 hypertension;32 or self-reported history of having physician-diagnosed high blood pressure; or self-reported anti-hypertensive medication use.

Hyperlipidemia was indicated if participants had a self-reported history of physician-diagnosed high cholesterol or triglycerides; or self-reported anti-hyperlipidemic medication use in the past 4 weeks.

Participants’ BMI was calculated based on height and weight measured at Wave IV as kg/m2. Respondents were considered obese if BMI was ≥30.

Diabetes was indicated if participants met at least one of the following criteria: either fasting glucose ≥126 mg/dL or non-fasting glucose ≥200 mg/dL or glycated hemoglobin (HbA1c) ≥6.5%; or self-reported history of having physician-diagnosed diabetes except during pregnancy; or self-reported anti-diabetic medication use.

Inflammation was measured by high-sensitivity C-reactive protein (hsCRP) and coded as a binary indicator of high inflammation if hsCRP was > 3mg/L. C-reactive protein is a widely measured biomarker of systemic inflammation, a well-established risk factor for the development and progression of cardiometabolic diseases.33,34

Metabolic syndrome represents a cluster of conditions that increases the risk of heart disease, stroke, and diabetes.35,36 Metabolic syndrome was indicated if participants had three or more of the following conditions: (1) blood pressure >130/85 mm Hg, or self-reported physician-diagnosed hypertension, or self-reported anti-hypertensive medication usage; (2) HbA1c ≥ 5.7%; (3) membership in the lowest two high-density lipoprotein (HDL) cholesterol deciles for women or the lowest three HDL deciles for men; (4) membership in the top three deciles of triglycerides; and (5) waist circumference ≥88cm for women or ≥102cm for men. This definition of metabolic syndrome has been used in previous studies of Add Health participants.37

Analytic Samples/Inclusion Criteria

We created an analytical dataset from the Add Health study sample at Wave I (n=20,745). We included only Wave I individuals who participated in Wave III and Wave IV; were geocoded; resided in the continental US (individuals residing in Alaska or Hawaii were excluded because air pollution data was not available for these states); and had non-missing data on key covariates, i.e., age, race/ethnicity, and sex (Figure 1). We also included only US-born participants, due to health differences by nativity status,38-41 and women who were not pregnant at Wave IV, as anthropometric and physiological markers differ for pregnant vs. non-pregnant women.

Figure 1.
Figure 1. Sample size restrictions flow chart

With these inclusion criteria, a maximum of 11,259 participants remained for statistical analyses. Sample sizes varied slightly across analyses depending on the health outcome, due to missing health measurements for some markers of cardiometabolic health (Figure 1).

Air pollution exposure

Air pollution exposure estimates were generated using the publicly available Fused Air Quality Surface using Downscaling (FAQSD) files (https://www.epa.gov/hesc/rsig-related-downloadable-data-files). The FAQSD files include daily predictions of 24-hour average PM2.5 concentrations and 8-hour maximum O3 concentrations at 2010 US Census tract centroids. The FAQSD files were generated using a statistical model (“downscaler”) that relates monitoring data and gridded output from the Community Multiscale Air Quality (CMAQ) model using a linear regression model with additive and multiplicative bias coefficients that can vary in space and time (see Supplemental Information for additional details).42,43

FAQSD files included predictions of daily 24-hour average PM2.5 concentrations and 8-hour maximum O3 concentrations at census tracts for 2002–07. We averaged daily values to generate annual average concentration estimates of tract-level 8-hour maximum O3 and 24-hour average PM2.5 for each year. Add Health participants were then matched to air pollution values based on their census tract(s) of residence and year. Residential location information on participants was available at each wave, but not for between-wave years, while air pollution data were obtained for 2002–07 (Figure 2). As illustrated in Figure 2, annual average PM2.5 and O3 concentrations from 2002–05 were attached to Add Health participants based on their census tract of residence at Wave III (2001–02) and annual average PM2.5 and O3 concentrations from 2006–09 were attached to Add Health participants based on their census tract of residence at Wave IV (2008–09). Because we did not have information on when individuals moved in between-wave years, for those who changed residences we assumed they moved close to the “midpoint” of years between waves.44 Thus, we assumed that Add Health participants resided at their Wave III address between 2002–05, and at their Wave IV address between 2006–09.

Figure 2.
Figure 2. Residential address collection, availability of air pollution data, and assignment of air pollution data to Add Health cohort membersa

a FAQSD air pollution data were not available in 2001, which is shown in gray. Air pollution data from 2008 and 2009 were merged with Add Health participant data as shown here, but air pollution data from 2008-2009 were not used in the present study.

We examined air pollution exposure and the key markers of cardiometabolic health at Wave IV in the analytical sample of 11,259 individuals. We used FAQSD output to estimate average PM2.5 and O3 exposures from 2002–07, which represents the long-term average air pollution exposure prior to collection of cardiometabolic health measures at Wave IV in 2008–09. Because FAQSD data are not available prior to 2002, we are unable to estimate air pollution exposure prior to 2002 using this particular data source.

Written informed consent was obtained at all waves and protocols approved by the Institutional Review Board of the University of North Carolina at Chapel Hill.

Statistical analysis

We calculated descriptive statistics of the study population, as well as average air pollution exposures by individual-level characteristics (e.g., age, sex, race/ethnicity). We tested for differences in 2002–07 O3 and PM2.5 concentrations by sex and racial/ethnic group, applying post-hoc tests for multiple pairwise comparisons and adjusting p-values for multiple comparisons using Bonferoni.45,46 To examine associations between air pollution exposures and markers of cardiometabolic health among young adults, we fit logistic regression generalized estimating equations (GEEs) to estimate the association between each air pollutant (O3, PM2.5) and health outcome. Models adjusted for Add Health participant’s age (years), sex, and race/ethnicity (non-Hispanic Black, Non-Hispanic White, Hispanic, Other): Embedded Image where πi is the probability of experiencing the outcome of interest for subject i. The coefficient β1 represents the estimated association between the health outcome and air pollution exposure averaged over 2002–07; the coefficients β2, β3, and β4 represent the associations of sex, race/ethnicity, and Wave IV age, respectively, with the outcome of interest. Models were fit separately for each pollutant and health outcome. An exchangeable correlation matrix was specified on the primary sampling unit ID in Add Health.47 We fit unweighted multivariable models with covariates adjusting for unequal selection into the sample and accounting for the clustered school design using GEEs.48

A two-sided α=0.05 was used to signify statistical significance. Statistical analyses were conducted using R statistical software.49 The gee package was used for fitting GEE models.50

Sensitivity analysis

As a sensitivity analysis, we fit adjusted models that estimated associations between air pollution exposure in 2006–07 and markers of cardiometabolic health measured at Wave IV. Analysis of 2002–07 air pollution exposure requires that individuals participated in both Waves III and IV, because their residential address at each wave is required to assign air pollution exposure. In contrast, analysis of 2006– 07 air pollution exposure only requires that individuals participated in Wave IV, because only a Wave IV address is used to assign air pollution exposure estimates for 2006 and 2007 (e.g., Figure 2). The 2006–07 exposure period represents lagged exposure in the years just prior to Wave IV. We conducted this sensitivity analysis to explore whether results were consistent: (1) across exposure averaging intervals, e.g., 2002–07 and 2006–07; and (2) using the slightly larger sample that is available for the 2006–07 analysis. We used the same set of restriction criteria previously applied to the sample of Wave III and IV participants, resulting in an analytical sample size of n=13,867 individuals for the sensitivity analysis (SM, Figure S1).

RESULTS

Descriptive statistics

Descriptive statistics of the study sample are provided in Table 1. At Wave IV, Add Health participants were, on average, 28 years old, and just over half the sample was female. Non-Hispanic White participants comprised over half of the sample (∼66%). The most common cardiometabolic health outcomes were high inflammation and obesity, followed by hypertension and metabolic syndrome.

View this table:
Table 1. Distributions of participants’ characteristics for those who participated in Wave III and Wave IV (n=11,259)a

Air pollution exposure

Air pollution exposure estimates are summarized in Table 2 overall, and by sex and race/ethnicity. Average O3 and PM2.5 exposures were 38.3 ppb and 12.7 μg/m3, respectively, over the 2002–07 period. T-tests with unequal variances were used to test for differences in O3 and PM2.5 concentrations by sex and the Kruskal-Wallis test was used to evaluate differences in 2002–07 air pollutant concentrations by racial/ethnic group.51 Air pollutant concentrations did not differ by sex, but there were differences between in PM2.5 and O3 by racial/ethnic group (p<0.0001).

View this table:
Table 2. Distributions of O3 and PM2.5 exposure by demographic characteristicsa

Non-Hispanic Black and non-Hispanic White groups had the highest O3 exposure (38.6 ppb); Other racial/ethnic groups (e.g., Asian, Native American, “other” race) had the lowest O3 exposure (36.1 ppb). For O3 exposure, Dunn’s test indicated that the non-Hispanic White group had different O3 exposures compared to Hispanic (p < 0.0001) and Other groups (p < 0.0001). The non-Hispanic Black group also had different O3 exposures compared to Hispanic (p < 0.0001) and Other groups (p < 0.0001). With respect to PM2.5, the non-Hispanic Black group had the highest PM2.5 exposure (13.6 μg/m3), while the non-Hispanic White group had the lowest PM2.5 exposure (12.2 μg/m3). Dunn’s tests indicated that the non-Hispanic Black group had different PM2.5 exposures compared to non-Hispanic White (p < 0.0001) and Hispanic groups (p < 0.0001). The non-Hispanic White group had different PM2.5 exposures compared to Hispanic (p < 0.0001) and Other groups (p < 0.0001). PM2.5 exposure in the Hispanic group differed from that in the Other group as well (p=0.00112).

Associations of air pollution exposure and health outcomes

Odds ratios (ORs) for associations of each air pollutant (O3 and PM2.5) with each health outcome are presented in Table 3. In GEEs adjusting for age, race/ethnicity, and sex, 2002–07 O3 exposure was associated with elevated odds of hypertension, with an OR of 1.015 (95% confidence interval [CI]: 1.011, 1.034); obesity (1.022 [1.004, 1.040]); diabetes (1.032 [1.009,1.054]); and metabolic syndrome (1.028 [1.014, 1.041]) (Table 3). In models adjusting for age, race/ethnicity, and sex, 2002–07 PM2.5 exposure was associated with elevated odds of hypertension (1.022 [1.001, 1.045]).

View this table:
Table 3. Wave IV health outcomes and air pollution exposure (2002-2007) in adjusted GEE logistic regression models a

Sensitivity analysis

Summary statistics of the analytic sample examined for 2006–07 exposure are provided in SM Table S1. Exposure to O3 in 2006–07 was associated with elevated odds of obesity (1.014 [1.003, 1.025]); diabetes (1.024 [1.004, 1.045]); inflammation (1.012 [1.003, 1.022]); and metabolic syndrome (1.013 [1.001, 1.026]) (SM Table S2). Statistically significant associations were not observed between 2006–07 PM2.5 exposure and health outcomes, although there was a marginal association of PM2.5 with hypertension (p=0.0518).

DISCUSSION

Add Health is a longstanding, nationally representative cohort of individuals with rich longitudinal data and a follow up period of nearly 25 years. Here, for the first time, we leverage the wealth of data available in this cohort to evaluate health outcomes in early adulthood that may be associated with long-term exposure to air pollution. Specifically, we: (1) examined whether multi-year exposures to O3 and PM2.5 differed by individual-level characteristics; and (2) estimated associations between air pollution exposure during the cohort’s early to mid-20s and multiple markers of cardiometabolic health measured when the cohort entered their late 20s.

We observed associations of 2002–07 O3 exposure with elevated odds of hypertension, obesity, diabetes, and metabolic syndrome. Results were similar for a shorter 2-year lagged period (2006–07) O3 exposure, which was associated with elevated odds of obesity, diabetes, metabolic syndrome, and inflammation. Long-term exposure to PM2.5 (2002–07) was associated with elevated odds of hypertension, and no statistically significant associations were observed between 2006 –07 PM2.5 exposure and health outcomes examined in our study.

Associations were in the expected direction, i.e., higher air pollution levels were associated with elevated odds of cardiometabolic outcomes, and we observed stronger evidence for associations between health outcomes and O3 compared to PM2.5.52 This is notable because the current body of evidence for cardiovascular and cardiometabolic health outcomes is strongest for PM2.5 exposure, although associations between O3 and cardiometabolic health have also been observed.53 For example, a 2021 meta-analysis of ambient air pollution exposure and blood pressure in children and adolescents concluded that short-term and long-term exposures to air pollution, specifically PM2.5, may increase blood pressure, but the authors stated that conclusions could not be drawn for O3 due to the limited number of studies.54 Our results suggest that investment in additional studies of O3 is warranted. Additionally, future work should evaluate whether more recent exposures or long-term, cumulative exposures are more relevant to health outcomes.

Although the magnitudes of the associations between air pollution exposure and health outcomes estimated here were small, air pollution exposure is ubiquitous, and elevated odd ratios applied to an entire population translate into substantial impacts on public health. Moreover, air pollution exposure is modifiable, and the public health risk it poses can be mitigated through regulation, e.g., more stringent ambient air quality standards. To this point, Brauer et al (2021) recently argued that because air pollution exposure is pervasive, reducing pollutant concentrations presents a powerful and critical opportunity to equitably reduce cardiovascular disease burden.13 The European Society of Cardiology also recognized air pollution exposure as a major modifiable risk factor relevant to the prevention of cardiovascular disease and emphasized the need for research regarding the role of air pollution in relation to early markers of cardiovascular health such as hypertension.55

Multiple cohort studies in the US have explored associations between air pollution exposures and cardiovascular and/or cardiometabolic health outcomes. To date, most have focused on middle aged and older adults with minimum ages of 45–50 years and/or are non-representative or small, geographically localized samples. Examples include the Multi-Ethnic Study of Atherosclerosis (MESA),5,56 Atherosclerosis Risk in Communities (ARIC),57 the Framingham Heart Study,58 the Jackson Heart Study,59 the Women’s Health Initiative (WHI),60 and the Study of Women’s Health Across the Nation (SWAN),61 among others. In these cohorts, associations have been observed between exposures to PM2.5 and/or O3 (e.g., ≥1 year) and: fatal and non-fatal cardiovascular events;60 diabetes;62 impaired renal function;63 systemic inflammation;58 and arterial injury and subclinical markers of arterial disease that are predictive of coronary heart disease and stroke in individuals without cardiovascular disease.7

The present study of the Add Health cohort is one of few that examines long-term air pollution exposures and cardiometabolic health outcomes in a national cohort of young adults from communities across the US. It adds to a growing body of literature on air pollution exposure and cardiometabolic health in children and young adults. For example, a study of 158 individuals in Southern California aged 17–22 years, found that one-year NO2 exposure was associated with higher fasting serum lipid measures (e.g., total cholesterol) and one-month O3 exposure was associated with higher triglyceride levels and lower HDL levels.64 Results of another study in Southern California that examined 173 young adults aged 18– 23 years suggested that long-term (e.g., ≥1 year) air pollution exposure may contribute to the metabolic dysfunction in youth through lipolysis and altered fatty acid metabolism.65 A third study from California observed that higher annual average PM2.5 exposure over 3 years of follow up was associated with more rapid declines in insulin sensitivity over time and lower insulin sensitivity, independent of adiposity, in overweight and obese children aged 8–15 years at enrollment.66 A longitudinal study of approximately 3,300 children in multiple Southern California communities enrolled at 9-10 years of age and followed until age 18 found that traffic density was associated with BMI at age 18, particularly in females.67 Although we did not observe associations between PM2.5, O3, and cholesterol specifically, our results add to the existing literature indicating long term air pollution exposure is associated with multiple measures of cardiometabolic health, even in young adults.

In addition to associations between air pollution exposure and health, we also observed differences in PM2.5 and O3 exposure by race/ethnicity. Non-Hispanic Black participants (and non-Hispanic White participants) had the highest O3 exposure, while Other race group participants had the lowest O3 exposure. Non-Hispanic Black participants also had the highest PM2.5 exposure, while non-Hispanic White participants had the lowest PM2.5 exposures. These findings are consistent with literature examining racial/ethnic disparities in air pollution exposure, which have generally found that non-Hispanic Blacks have higher exposures to air pollutants, especially PM2.5.68-71 This disparity may reflect, among other things, documented patterns of siting hazardous waste sites, polluting industrial facilities, and other undesirable activities or contaminated land-use types disproportionately in communities with lower socioeconomic status and a higher proportion of minoritized racial/ethnic groups.71,72 For this reason, it has been argued that reducing air pollution exposure is one potential pathway for reducing racial/ethnic disparities in cardiometabolic health.13

This study has several limitations. Add Health collects current residential address at each wave but does not collect residential histories. Thus, we do not have between-wave residential address information. Average air pollution exposures were estimated assuming that individuals resided at their Wave III residential address between 2002–05, and Wave IV residential address between 2006–07. Additionally, the FAQSD data attached to the Add Health data and used to estimate air pollution exposures was only available at the census tract level and are not available prior to 2002. Air pollution estimates continue to evolve with increasingly higher resolution and made publicly available. Future studies of high-resolution estimates, including data prior to 2002, are needed in Add Health and other cohorts.

However, this study has important strengths. This is the first study of air pollution exposures and health outcomes in the Add Health cohort. This cohort represents a large national sample of young people that includes individuals from across the US, in both urban and rural environments, and is a longstanding cohort with rich individual- and contextual-level longitudinal data. Although associations between air pollution exposure and cardiovascular and cardiometabolic health have been evaluated in other study cohorts, prior results were derived from overwhelmingly middle aged and older cohorts and/or were based on small or local samples. Examining health outcomes earlier in the life course may provide more insight into the relevance of environmental exposures in developing early markers of cardiometabolic health (or disease) and thus more opportunities for early, targeted, and/or preventative or mitigative intervention.

This study adds to the body of evidence that exposures of air pollutants may be key risk factors for cardiovascular disease, including hypertension, high BMI, diabetes, inflammation, and metabolic syndrome in early life.26,53 Biological mechanisms through which air pollution influences development of cardiovascular and cardiometabolic disease, or risk factors for disease have been postulated, including increased systemic inflammation,73,74 platelet activation in the bloodstream,75,76 autonomic nervous system changes,77,78 alterations in the vascular cell type composition,74 and alterations in the gut microbiome,79 but overall remain poorly understood. Future research would benefit from bringing together longitudinal studies representing a broad lifespan (childhood, adolescent, and adulthood) with repeated biological assessments, precisely measured environmental exposures capturing critical development periods, and clinical follow-up to better understand if and how long-term air pollution exposures shape cardiovascular and cardiometabolic disease risks across the life course.

Data Availability

All air pollution exposure data are publicly available online: https://www.epa.gov/hesc/rsig-related-downloadable-data-files. All health-related data is available through the Add Health Survey, which has both restricted and public use data sets. Data used here was part of the restricted use data set, access to which can be obtained through applying at the Data Portal: https://addhealth.cpc.unc.edu/data/#restricted-use. Written informed consent was obtained at all waves and the study and study protocols were approved by the Institutional Review Board of the University of North Carolina at Chapel Hill.

Funding sources

This research uses data from Add Health, funded by grant P01 HD31921 (Harris) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), with cooperative funding from 23 other federal agencies and foundations. Add Health is currently directed by Robert A. Hummer and funded by the National Institute on Aging cooperative agreements U01 AG071448 (Hummer) and U01AG071450 (Aiello and Hummer) at the University of North Carolina at Chapel Hill. Add Health was designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill. Support was provided by the RTI University Scholars program (Harris), Whitehead Scholars program at Duke School of Medicine (Bravo), and the RTI Fellow program (Johnson).

Disclosures

None to declare.

Conflict of interest

None to declare

ACKNOWLEDGEMENTS

REFERENCES

  1. 1.↵
    World Health Organization. Review of evidence on health aspects of air pollution. Geneva, Switzerland 2013.
  2. 2.↵
    Krall JR, Anderson GB, Dominici F, Bell ML, Peng RD. Short-term exposure to particulate matter constituents and mortality in a national study of U.S. urban communities. Environmental Health Perspectives. 2013;121(10).
  3. 3.
    Crouse DL, Peters PA, Hystad P, et al. Ambient PM2.5, O3, and NO2 exposures and associations with mortality over 16 years of follow-up in the Canadian Census Health and Environment Cohort (CanCHEC). Environmental Health Perspectives. 2015;123:1180–1186.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. Ozone and short-term mortality in 95 US urban communities, 1987-2000. Journal of the American Medical Association. 2004;292(19):2372–2378.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Kaufman JD, Adar SD, Barr RG, et al. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): A longitudinal cohort study. The Lancet. 2016;388(10045):696–704.
    OpenUrlCrossRef
  6. 6.
    Kaufman JD, Elkind MSV, Bhatnagar A, et al. Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association. Circulation. 2020;142(23).
  7. 7.↵
    Wang M, Sampson PD, Sheppard L, Stein JH, Vedal S, Kaufman JD. Long-Term Exposure to Ambient Ozone and Progression of Subclinical Arterial Disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution. Environmental Health Perspectives. 2019;127(5).
  8. 8.↵
    Kirwa K, Eckert CM, Vedal S, Hajat A, Kaufman JD. Ambient air pollution and risk of respiratory infection among adults: Evidence from the multiethnic study of atherosclerosis (MESA). BMJ Open Respiratory Research. 2021;8(1).
  9. 9.↵
    Dominici F, Peng RD, Bell ML, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. Journal of the American Medical Association. 2006;295(10):1127–1134.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Bravo MA, Ebisu K, Dominici F, Wang Y, Peng R, Bell ML. Airborne fine particles and risk of hospital admissions for understudied populations: Effects by urbanicity and short-term cumulative exposures in 708 US communities. Environmental Health Perspectives. 2017;125(4):594–601.
    OpenUrlPubMed
  11. 11.↵
    Di Q, Wang Y, Zanobetti A, et al. Air Pollution and Mortality in the Medicare Population. New England Journal of Medicine. 2017;376:2513–2522.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Makar M, Antonelli J, Di Q, Culter D, Schwartz J, Dominici F. Estimating the Causal Effect of Fine Particulate Matter Levels on Death and Hospitalization: Are Levels Below the Safety Standards Harmful? Epidemiology. 2017;28(5):627–634.
    OpenUrlPubMed
  13. 13.↵
    Brauer M, Casadei B, Harrington RA, Kovacs R, Sliwa K, WHF Air Pollution Expert Group. Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion From the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology. Circulation. 2021;143(14):e800–e804.
    OpenUrl
  14. 14.↵
    Ljungman PLS, Li W, Rice MB, et al. Long- and short-term air pollution exposure and measures of arterial stiffness in the Framingham Heart Study. Environment International. 2018;121:139–147.
    OpenUrl
  15. 15.↵
    Kaufman JD, Adar SD, Barr RG, et al. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study. Lancet. 2016;388:696–704.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Chan SH, Van Hee VC, Bergen S, et al. Long-Term Air Pollution Exposure and Blood Pressure in the Sister Study. Environmental Health Perspectives. 2015;123(10):951–958.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Jerrett M, McConnell R, Wolch J, et al. Traffic-related air pollution and obesity formation in children: a longitudinal, multilevel analysis. Environmental Health. 2014;13.
  18. 18.↵
    Bowe B, Gibson AK, Xie Y, et al. Ambient Fine Particulate Matter Air Pollution and Risk of Weight Gain and Obesity in United States Veterans. Environmental Health Perspectives. 2021;129(4).
  19. 19.↵
    Yu Y, Jerrett M, Kimberly C, et al. Ozone Exposure, Outdoor Physical Activity, and Incident Type 2 Diabetes in the SALSA Cohort of Older Mexican Americans. Environmental Health Perspectives. 2021;129(9).
  20. 20.↵
    Jerrett M, Brook R, White LF, et al. Ambient ozone and incident diabetes: A prospective analysis in a large cohort of African American women. Environment International. 2017;102:42–47.
    OpenUrlCrossRef
  21. 21.↵
    Farzan SF, Habre R, Danza P, et al. Childhood traffic-related air pollution and adverse changes in subclinical atherosclerosis measures from childhood to adulthood. Environemntal Health. 2021;20(44).
  22. 22.↵
    Jerrett M, McConnell R, Chang CC, et al. Autombile traffic around thehoem and attained body mass index: a longitudinal study of children aged 10-18 years. Preventative Medicine. 2014;50:S50–S58.
    OpenUrl
  23. 23.↵
    Li J, Zhou C, Xu H, et al. Ambient Air Pollution Is Associated With HDL (High-Density Lipoprotein) Dysfunction in Healthy Adults. Arterioscler Thromb Vasc Biol. 2019;39(3):513–522.
    OpenUrl
  24. 24.↵
    McGuinn LA, Schneider AM R.W., Ward-Caviness CK, et al. Association of long-term PM2.5 exposure with traditional and novel lipid measures related to cardiovascular disease risk. Environment International. 2019;122:193–200.
    OpenUrlPubMed
  25. 25.↵
    Xu H, Chen J, Zhao Q, et al. Ambient air pollution is associated with cardiac repolarization abnormalities in healthy adults. Environmental Research. 2019;171:239–246.
    OpenUrl
  26. 26.↵
    Kim JB, Prunicki M, Haddad F, et al. Cumulative Lifetime Burden of Cardiovascular Disease from Early Exposure to Air Pollution. Jouranl of the American Heart Association. 2020;9(6).
  27. 27.↵
    Harris KM. The Add Health Study: Design and Accomplishments. Carolina Population Center at the University of North Carolina at Chapel Hill;2013.
  28. 28.↵
    Harris KM, Halpern CT, Hussey JM, et al. Social, Behavioral, and Genetic Linkages from Adolescence Into Adulthood. American Journal of Public Health. 2013;103:S25–S32.
    OpenUrlCrossRef
  29. 29.↵
    Brownstein N, Kalsbeek WD, Tabor J, Entzel P, Daza E, Harris KM. Non-response in wave IV of the National Longitudinal Study of Adolescent Health. Chapel Hill: University of North Carolina; 2011.
  30. 30.↵
    Kalsbeek WD, Morris CB, Vaughn BJ. Effects of Nonresponse On the Mean Squared Error of Estimates From a Longitudinal Study. 2002.
  31. 31.↵
    Harris KM, Halpern CT, Whitsel EA, et al. Cohort Profile: The National Longitudinal Study of Adolescent to Adult Health (Add Health). International Journal of Epidemiology. 2019;48(5):1415–1415k.
    OpenUrlPubMed
  32. 32.↵
    National High Boood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: National Institutes of Health; 2004.
  33. 33.↵
    Onat A, Can G, Hergenc G. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism. 2008;57(2):207–214.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–1832.
    OpenUrlCrossRefPubMed
  35. 35.↵
    Motillo S, Filion K, Gest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysi. Journal of the American College of Cardiology. 2010;56(14):1113–1132.
    OpenUrlFREE Full Text
  36. 36.↵
    Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    Gaydosh L, Chen E, Miller GE, Harris KM. College completion predicts lower depression but higher metabolic syndrome among disadvantaged minorities in young adulthood. Proceedings of the National Academy of Sciences. 2018;115(1):109–114.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    Crosnoe R. Health and the Education of Children from Racial/Ethnic Minority and Immigrant Families. Journal of Health and Social Behavior. 2006;47(1):77–93.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.
    Harris KM, Perreira KM, Lee D. Obesity in the Transition to Adulthood: Predictions across Race/Ethnicity, Immigrant Generation, and Sex. Archives of Pediatrics & Adolescent Medicine 2009;163(11):1022–1028.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.
    Hummer RA, Rogers RG, Nam CB, LeClere FB. Race/Ethnicity, Nativity, and US Adult Mortality Social Science Quarterly 1999:136–153.
  41. 41.↵
    Singh GK, Miller BA. Health, Life Expectancy, and Mortality Patterns among Immigrant Populations in the United States. Canadian Journal of Public Health. 2004;95(3):14–21.
    OpenUrl
  42. 42.↵
    Berrocal VJ, Gelfand AE, Holland DM. A bivariate space-time downscaler under space and time misalignment. Ann Appl Stat. 2010;4(4):1942–1975.
    OpenUrlPubMed
  43. 43.↵
    Berrocal VJ, Gelfand AE, Holland DM. Space-time data fusion under error in computer model output: an application to modeling air quality. Biometrics. 2012;68(3):837–848.
    OpenUrl
  44. 44.↵
    Bravo MA, Fang F, Hancock DB, Johson EO, Harris KM. The National Longitudinal Study of Adolescent to Adult Health, Multi-year air pollution exposure estimates for Add Health Waves III-V. Chapel Hill, NC: University of North Carolina at Chapel Hill;2022.
  45. 45.↵
    Dunn OJ. Multiple comparisons using rank sums. Technometrics. 1964;6:241–252.
    OpenUrlCrossRef
  46. 46.↵
    Glantz SA. Primer of Biostatistics. New York: McGraw Hill; 2012.
  47. 47.↵
    Liang KY, Zeger SL. Longitudinal Data Analysis Using Generalized Linear Models. Biometrika. 1986;73:13–22.
    OpenUrlCrossRefWeb of Science
  48. 48.↵
    Zhang J, McLaughlin S, Li L. Cumulative exposure to air pollution and subsequent mortality among older adults in China. Journal of Public Health. 2018;41(3):518–526.
    OpenUrl
  49. 49.↵
    R Core Team. A language and environment for statistical computing. 2019.
  50. 50.↵
    Halekoh U, Hojsgaard S. The R Package geepack for Generalized Estimating Equations. Journal of Statistical Software. 2006;15(2).
  51. 51.↵
    Hollander M, Wolfe DA. Nonparametric statistical methods. New York: John Wiley & Sons, Inc.; 1973.
  52. 52.↵
    Jerrett M, Brook R, White LF, et al. Ambient ozone and incident diabetes: A prospective analysis in a large cohort of African American women. Environment International. 2017;102:42–47.
    OpenUrlCrossRef
  53. 53.↵
    Brook RD, Rajagopalan S, Pope III AP, et al. Particulate Matter Air Pollution and Cardiovascular Disease: An Update to the Scientific Statement From the American Heart Association. Circulation. 2010;121(21).
  54. 54.↵
    Huang M, Chen J, Yang Y, Yuan H, Huang Z, Lu Y. Effects of Ambient Air Pollution on Blood Pressure Among Children and Adolescents: A Systematic Review and Meta-Analysis. Journal of the American Heart Association. 2021;10(10).
  55. 55.↵
    Newby DE, Mannucci PM, Tell GS, et al. Expert position paper on air pollution and cardiovascular disease. European Heart Journal. 2015;36(2):83–93.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    Gill EA, Curl CL, Adar D, et al. Air Pollution and Cardiovascular Disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Progress in Cardiovascular Diseases. 2011;53(5):353–360.
    OpenUrlCrossRefPubMed
  57. 57.↵
    Kan H, Folson AR, Cushman M, et al. Traffic exposure and incident venous thromboembolism in the Atherosclerosis Risk in Communities (ARIC) Study. Journal of Thrombosis and Haemostasis. 2011;9(4):672–678.
    OpenUrl
  58. 58.↵
    Li W, Dorans KS, Wilker EH, et al. Short-Term Exposure to Ambient Air Pollution and Biomarkers of Systemic Inf. Arteriosclerosis, Thrombosis, and Vascular Biology. 2017;37(9):1793–1800.
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    Weaver AM, Wang Y, Wellenius GA, et al. Long-Term Air Pollution and Blood Pressure in an African American Cohort: the Jackson Heart Study. American Journal of Preventative Medicine. 2021;60(3):397–405.
    OpenUrl
  60. 60.↵
    Miller KA, Siscovick DS, Sheppard L, et al. Long-Term Exposure to Air Pollution and Incidence of Cardiovascular Events in Women. New England Journal of Medicine. 2007;356:447–458.
    OpenUrlCrossRefPubMedWeb of Science
  61. 61.↵
    Duan C, Talbott E, Brooks M, et al. Five-year exposure to PM2.5 and ozone and subclinical atherosclerosis in late midlife women: The Study of Women’s Health Across the Nation. International JOurnal of Hygiene and Environmental Health. 2019;222(2):168–176.
    OpenUrl
  62. 62.↵
    Weaver AM, Bidulescu A, Wellenius GA, et al. Associations between air pollution indicators and prevalent and incident diabetes in an African American cohort, the Jackson Heart Study. Environmental Epidemiology. 2021;22(5).
  63. 63.↵
    Weaver AM, Wang Y, Wellenius GA, et al. Long-term exposure to ambient air pollution and renal function in African Americans: the Jackson Heart Study. Journal of Exposure Science and Environmental Epidemiology. 2019;29(4):548–556.
    OpenUrl
  64. 64.↵
    Kim JS, Chen Z, Alderete TL, et al. Associations of air pollution, obesity and cardiometabolic health in young adults: The Meta-AIR study. Environment International. 2019;133.
  65. 65.↵
    Chen Z, Newgard CB, Kim JS, et al. Near-roadway air pollution exposure and altered fatty acid oxidation among adolescents and young adults – The interplay with obesity. Environment International. 2019;130.
  66. 66.↵
    T.L. Alderete RH C.M. Toledo-Corral, et al., Alderete TL, Habre R, et al. Longitudinal associations between ambient air pollution with insulin sensitivity, beta-cell function, and adiposity in Los Angeles Latino children. Diabetes. 2017;66(7):1789–1796.
    OpenUrlAbstract/FREE Full Text
  67. 67.↵
    Jerrett M, McConnell R, Chang CCR, et al. Automobile traffic around the home and attained body mass index: a longitudinal cohort study of children aged 10-18 years. Preventative Medicine. 2010;50:S50–S58.
    OpenUrlCrossRefPubMed
  68. 68.↵
    Bell ML, Ebisu K. Environmental inequality in exposures to airborne particulate matter components in the United States. Environmental Health Perspectives. 2012;120:1699–1704.
    OpenUrlPubMedWeb of Science
  69. 69.
    Bravo MA, Anthopolos R, Bell ML, Miranda ML. Racial isolation and exposure to airborne particulate matter and ozone in understudied US populations: Environmental justice applications of downscaled numerical model output. Environ Int. 2016;92-93:247–255.
    OpenUrlCrossRefPubMed
  70. 70.
    Jbaily A, Zhou X, Liu J, et al. Air pollution exposure disparities across US population and income groups. Nature. 2022;601:228–233.
    OpenUrl
  71. 71.↵
    Tessum CW, Paolella DA, Chambliss SE, Apte JS, Hill JD, Marshall JD. PM2.5 polluters disproportionately and systemically affect people of color in the United States. Science Advances. 2021;7(18).
  72. 72.↵
    Mohai P, Saha R. Which came first, people or pollution? Assessing the disparate siting and post-siting demographic change hypotheses of environmental injustice. Environmental Research Letters. 2015;10.
  73. 73.↵
    Hartz AMS, Bauer B, Block ML, Hong J-S, Miller DS. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. Federation of American Societies for Experimental Biology. 2008;22:2723–2733.
    OpenUrl
  74. 74.↵
    Törnqvist H, Mills NL, Gonzalez M, et al. Persistent endothelial dysfunction in humans after diesel exhaust inhalation. American Journal of Respiratory and Critical Care Medicine. 2007;176(395-400).
  75. 75.↵
    Hoek G, Brunekreef B, Fischer P, van Wijnen J. The association between air pollution and heart failure, arrhythmia, embolism, thrombosis, and other cardiovascular causes of death in a time series study. Epidemology. 2001;12:355–357.
    OpenUrl
  76. 76.↵
    Bonzini M, Tripodi A, Artoni A, et al. Effects of inhalable particulate matter on blood coagulation. J Thromb Haemost. 2010;8:662–668.
    OpenUrlCrossRefPubMed
  77. 77.↵
    Rhoden CR, Wellenius GA, Ghelfi E, Lawrence J, González-Flecha B. PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation. Biochim Biophys Acta. 2005;1725:303–313.
    OpenUrl
  78. 78.↵
    Pieters N, Plusquin M, Cox B, Kicinski M, Vangronsveld J, Nawrot TS. An epidemiological appraisal of the association between heart rate variability and particulate air pollution: A meta-analysis. Heart. 2012;98.
  79. 79.↵
    Fouladi F, Bailey MJ, Patterson WB, et al. Air pollution exposure is associated with the gut microbiome as revealed by shotgun metagenomic sequencing. Environment International. 2020;138(105604).
  80. 80.
    Byun D, Schere K. Review of the governing equations, computational algorithms, and other components of the models-3 community multiscale air quality (CMAQ) modeling system. Appl Mech Rev. 2006;59:51–77.
    OpenUrlCrossRefWeb of Science
  81. 81.
    Houyoux MR, Vukovich JM, Coats Jr CJ, Wheeler NJM, Kasibhatla PS. Emission inventory development and processing for the Seasonal Model for Regional Air Quality (SMRAQ) project. Journal of Geophysical Research: Atmospheres. 2000;105(D7):9079–9090.
    OpenUrl
Back to top
Posted December 08, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Long-term air pollution exposure and markers of cardiometabolic health in the National Longitudinal Study of Adolescent to Adult Health (Add Health) Study
Mercedes A. Bravo, Fang Fang, Dana B. Hancock, Eric O. Johnson, Kathleen Mullan Harris
medRxiv 2022.12.07.22283112; doi: https://doi.org/10.1101/2022.12.07.22283112
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area